|
|
7811 Eads Ave. Suite 112
San Diego, CA 92037 USA
phone:858-551-0096
fax:
|
|
| Symbol |
Private |
| Founded |
2006 |
| Employees |
|
|
|
| freedom-meditech.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Non-Invasive Ocular Glucose Measurement |
|
| Management |
| Craig H. Misrach, M.B.A., C.P.A., President and Chief Executive Officer; Brent D. Cameron, Ph.D., Chief Scientific Officer; Brian Catanzaro, Ph.D., VP of Product Development, Lead Optical Engineer |
| |
|
|
| |
|
| Keywords |
| Diabetes, non-invasive glucose measurement |
|
|
|
| Description |
|
Freedom Meditech, Inc. is a developmental stage medical device company focused on the in-licensing, development, and commercialization of novel technology for the management of diabetes. |
|
| Technology / Differentiation |
| Freedom Meditech's current core proprietary technology is a novel diabetes medical device that is being developed to provide patients with a more convenient and pain-free alternative to the 'finger pricking' method of glucose measurement and monitoring. Their patented technology platform is; 1) non-invasive; 2) entails shining a light in a person's eye to obtain glucose information; and 3) is being designed to display glucose information in digital format on a small handheld device. |
|
| Market / Customers |
The worldwide diabetes market is currently estimated at $8 billion; the company's product presents significant potential in this market since no non-invasive blood glucose measuring device has yet been approved by the FDA.
|
|
| Strategy |
Freedom Meditech, Inc. was incorporated in December 2006, with the intent of licensing, developing, and commercializing medical devices with clear market need and overall global appeal.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members